SIRT2 and Parkinson disease: Increased neuronal survival after the treatment of ICL-SIRT07 in a lactacystin-induced PD model of N27 cells has proved that SIRT2 inhibition could be a potential strategy for the treatment of PD (Di Fruscia et al., 2015).